13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • WEHI

    Acronym: 

    WEHI

    ACTRN/NCT /ethics: 

    Scientific title: 

    Registry-based Study of Enzalutamide vs Abiraterone assessing cognitive function in Elderly Metastatic Castration-Resistant Prostate Cancer

    Summary of trial and patient characteristics

    Cancer Type Prostate
    Trial Type Treatment
    Phase All phases Tumour Stream Prostate
    Age Range 18 years and older Cancer Stage Metastatic or Widespread
    Sex Male Anticipated Start Date
    Molecular Target Anticipated End Date
    Cancer Type Prostate
    Trial Type Treatment
    Phase All phases
    Age Range 18 years and older
    Sex Male
    Molecular Target
    Tumour Stream Prostate
    Cancer Stage Metastatic or Widespread
    Anticipated Start Date
    Anticipated End Date

    Trial Summary

    Registry-based Study of Enzalutamide vs Abiraterone assessing cognitive function in Elderly Metastatic Castration-Resistant Prostate Cancer

    Lay Summary

    Registry-based Study of Enzalutamide vs Abiraterone assessing cognitive function in Elderly Metastatic Castration-Resistant Prostate Cancer

    Sponsor / Cooperative group

    REAL-PRO Study

    Participating Hospitals

    Hospital Clinical Trial Coordinator Email Phone Principal Investigator Recruitment Status
    Ashford Cancer Centre Research Sue Yeend syeend@adelaidecancercentre.com.au 08 8292 2240 Recruiting